2004 Annual Meeting | Neuromuscular Therapy

��ɫ��

2004 Annual Meeting | Neuromuscular Therapy

Date Wednesday 04/28/04

Time 07:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Therapy Program

Director(s) John T. Kissel, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Upon completion:
Participants should be able to utilize recent advances in therapy for various incurable neuromuscular diseases; understand the rationale for certain experimental trials in these disorders; and appreciate the role of palliative care in treating these patients.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse, Other

Event Timeline
07:00 PM - 07:35 PM		Clinical Approach to the Management of the Muscular Dystrophies John T. Kissel, MD, FAAN
07:35 PM - 08:10 PM		Clinical Approach to the Management of ALS Carlayne E. Jackson, MD, FAAN
08:10 PM - 08:45 PM		What We Can Do When There is Nothing More We Can Do: The Role of Palliative Care Robert M. Taylor, MD, FAAN
08:45 PM - 09:00 PM		Questions and Answers

Faculty Disclosures
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.
Robert M. Taylor, MD, FAAN	No disclosure on file
Carlayne E. Jackson, MD, FAAN	Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma America. Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��